Those are massive questions, and I can see the chair in front of me telling me not to take too long.
On malaria, the interventions vary greatly between, for example, a high-burden setting like the Sahel or an area where the incidents are not too high but you want to eliminate malaria. Let's remember that our goal is to eliminate malaria. Sometimes this last mile, such as in the Mekong area where the rates are not very high, to reach elimination requires very focused interventions so that we can eliminate it. Then it's done. We don't need to go back to that.
So it varies, but one thing we've been investing in a lot is a new generation of bed nets that can be much more effective against the vector. We're investing a lot in that area. On HIV....
The chair is asking to me wrap up.
It's a mix of interventions. We find ourselves investing in areas that are very far from biomedical inventions—giving money to girls so that they stay in school, strengthening girls' empowerment groups, running programs to prevent gender-based violence, supporting adolescent-friendly prevention programs and sexual education programs.
We're investing in all of that, but the only way we can do that is through partners. It's not the Global Fund that does that. It's working with communities through societal organizations, youth organizations and women's organizations on the ground. Through doing that, we can address the high level of prevalence in adolescent girls and young women, and similarly with key populations. That's the model we need to fight—